Answers are grounded in this paper and cite their sources.
OBJECTIVE: To compare oncologic outcomes and facial motor function between nerve-preserving (NP) dissection and nerve-sacrificing (NS) resection with immediate reconstruction in malignant parotid tumors where the facial nerve is closely associated, degenerated, but anatomically identifiable. METHODS: The authors retrospectively reviewed patients with malignant parotid tumors treated at a single tertiary center from February 2020 to February 2022. Cases with intraoperative tumor-nerve adhesion and neural degeneration were assigned to either the NP or NS group. Propensity score matching was applied to reduce confounding. Outcomes included recurrence-free survival, event-free survival, and facial nerve function at last follow-up. RESULTS: One hundred forty-five patients were included (96 NPs, 49 NS). After matching, each group included 47 patients. Recurrence-free survival was 74.5% versus 76.6% and event-free survival was 68.1% versus 59.6% in the NP dissection and nerve resection with reconstruction groups, respectively (P>0.05). Cox multivariate regression analysis showed that neither nerve management nor radiotherapy influenced recurrence-free or event-free survival (P>0.05). Facial nerve function at final follow-up was significantly associated with intraoperative management (P<0.001). Binary logistic regression analysis confirmed that nerve resection significantly increased the risk of postoperative facial paralysis (odds ratio=11.358, 95% confidence interval: 3.805-33.899, P<0.001). CONCLUSION: In malignant parotid tumors where the facial nerve is degenerated but anatomically identifiable, nerve sacrifice does not improve oncologic outcomes but leads to significantly worse facial function. Nerve preservation should be performed whenever possible.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: